Analyzing the Value of an Educational Program, a regular doctor-patient contact and our app for Psoriasis Patients on the satisfaction with healthcare, quality of life and outcomes of patients suffering from moderate to severe psoriasis with or without psoriatic arthritis

Analyzing the Value of an Educational Program, a regular doctor-patient contact and our app for Psoriasis Patients on the satisfaction with healthcare, quality of life and outcomes of patients suffering from moderate to severe psoriasis with or without psoriatic arthritis - PSO_App

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00020755

Enrollment

100

Registered

2020-02-12

Start date

2018-01-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L40

Interventions

Group 1: Intervention group: After being included in the study, the psoriasis patients in the intervention group took part in a educational program treating the topics: therapy options, common comorbi

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria were an age between 18 and 75 years, the ability to provide informed consent, and suffering from moderate to severe psoriasis (PASI> 10, or BSA> 10 and DLQI> 10 or extensive scalp infestation, palms, soles of the feet) and / or genitalia and / or onycholysis and / or onychodystrophy of at least two fingernails).

Exclusion criteria

Exclusion criteria: Exclusion criteria were the inability to understand and read German

Design outcomes

Primary

Measure	Time frame
1. To determine the impact of patient education for patients with psoriasis, a regular doctor-patient and contact through and our app, on therapy compliance, therapy satisfaction (using a compliance questionnaire and a visual analog scale on our app), itching (using a visual analog scale), pain (using a visual analogue scale), the quality of life (based on the Dermatology Quality of Life Index (DLQI), the psychological state of patients (based on the Hospital Anxiety and Depression Scale (HADS)) and the PBI (Patient Benefit Index) for patients who suffer from moderate to severe psoriasis with or without psoriatic arthritis. 2. Acceptance test of the smartphone application of our APP (clinical study for the approval of the APP as a medical device type I).	—

Measure

Time frame

1. To determine the impact of patient education for patients with psoriasis, a regular doctor-patient and contact through and our app, on therapy compliance, therapy satisfaction (using a compliance questionnaire and a visual analog scale on our app), itching (using a visual analog scale), pain (using a visual analogue scale), the quality of life (based on the Dermatology Quality of Life Index (DLQI), the psychological state of patients (based on the Hospital Anxiety and Depression Scale (HADS)) and the PBI (Patient Benefit Index) for patients who suffer from moderate to severe psoriasis with or without psoriatic arthritis. 2. Acceptance test of the smartphone application of our APP (clinical study for the approval of the APP as a medical device type I).

—

Secondary

Measure	Time frame
1. To determine the impact of a educational program for psoriasis patients, a regular doctor-patient contact and our app on the severity of the disease (based on the Psoriasis Area and Severity Index (PASI)), the disease activity of psoriatic arthritis (based on the Classification criteria for Psoriatic Arthritis (CASPAR Scores) and the Classification criteria for Psoriatic Arthritis (BASDAI scores) in patients suffering from moderate to severe psoriasis with or without psoriatic arthritis. 2. Analysing the impact of an educational program for patients with psoriasis on the level of knowledge about psoriasis collected using a questionnaire. 3.Evaluation of the educational program and the app by the patients using free text and multiple choice questions.	—

Measure

Time frame

1. To determine the impact of a educational program for psoriasis patients, a regular doctor-patient contact and our app on the severity of the disease (based on the Psoriasis Area and Severity Index (PASI)), the disease activity of psoriatic arthritis (based on the Classification criteria for Psoriatic Arthritis (CASPAR Scores) and the Classification criteria for Psoriatic Arthritis (BASDAI scores) in patients suffering from moderate to severe psoriasis with or without psoriatic arthritis. 2. Analysing the impact of an educational program for patients with psoriasis on the level of knowledge about psoriasis collected using a questionnaire. 3.Evaluation of the educational program and the app by the patients using free text and multiple choice questions.

—

Countries

Germany

Contacts

Public ContactAstrid Schmieder

Klinik für Dermatologie, Universitätsmedizin Mannheim

astrid.schmieder@umm.de0621-383-2280

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 14, 2026